 |
|
| Blog results | Results 1 - 10 of about 39,426 for abbott laboratories. (0.26 seconds) |
| Sorted by relevance Sort by date |
| Related Blogs: | Abbott Labs: Global Health Care & Medical Research - http://www.abbott.com/ | |
| 20 Nov 2009 by odorcable BUY rating on Abbott Laboratories (ABT) Start Price: $53.64 Start Date: 11/21/2009 Allocation: 7.0% of portfolio. SocialPicks.com: Recent Picks - http://www.socialpicks.com/ [ More results from SocialPicks.com: Recent Picks ] |
| 19 hours ago by admin FDA is sifting through some preliminary data suggesting that Abbott Laboratories' obesity drug Meridia (sibutramine) may carry cardiovascular risks. At this point the operative word is preliminary; the agency says it's making no ... VitaminsHealth.net - http://www.vitaminshealth.net/ |
| 12 Nov 2009 by AP September 18th, 2009 FDA approves new HIV test from Abbott LaboratoriesWASHINGTON — The Food and Drug Administration has approved a new test from Abbott Laboratories that detects both types of the virus that causes AIDS. ... Health News - http://blog.taragana.com/health/ [ More results from Health News ] |
| 12 Nov 2009 ABBOTT PARK, Ill., Nov. 12 /PRNewswire-FirstCall/ -- Abbott announced today a definitive agreement to acquire the global rights to PanGenetics BV's PG110 fully humanized antibody to Nerve Growth Factor (NGF), expanding the company's ... BioSpace.com Featured News and Stories - http://www.biospace.com/ [ More results from BioSpace.com Featured News and Stories ] |
| 12 Nov 2009 by admin Abbott Labs has agreed to acquire the global rights to an antibody to nerve growth factor from PanGenetics BV, a Dutch antibody developer. The deal includes a $170 million up-front payment and up to $20 million in additional earn-outs. ... PE Hub Blog - http://www.pehub.com/ - References [ More results from PE Hub Blog ] |
| 12 Nov 2009 Wedbush Pac Grow initiated coverage of the health-care firm at Outperform. Barron's This Week Magazine - http://online.barrons.com/home-page - References |
| 7 hours ago by ex-Hollywood Liberal Consulting Fees from Abbott Laboratories; Avexa Limited; Boehringer Ingelheim Pharmaceuticals, Inc.; Bristol-Myers Squibb Company; Gilead Sciences Medical Affairs; GlaxoSmithKline; Human Genome Sciences, Inc.; Idenix Pharmaceuticals, ... Hollywood Gumshoe - http://exlibhollywood.blogspot.com/ |
| 12 Nov 2009 Abbott Laboratories (NYSE: ABT) opened at $53.39. So far today, the stock has hit a low of $53.01 and a high of $53.80. ABT is now trading at $53.23, down $0.04 (-0.08%). Over the last 52 weeks the stock has ranged from a low of $41.27 ... MarketIntelligenceCenter.com - http://www.marketintelligencecenter.com/ [ More results from MarketIntelligenceCenter.com ] |
| 20 Nov 2009 by Basdeo Hiralal On Wednesday and Thursday, The Deal was in conference mode, hosting panels of high-profile dealmakers on financial and corporate sides, doing post-panel video interviews and live-blogging. The two-day Deal Economy 2010 event was capped ... The Deal.com - http://www.thedeal.com/ - References |
| 4 Nov 2009 by Ryan McBride There's big news about Enlight Biosciences breaking here at the Xconomy Forum: Pharma's Bet on Boston Innovation. Abbott Laboratories (NYSE:]) has joined the. Xconomy Energy Feed - http://www.xconomy.com/ - References [ More results from Xconomy Energy Feed ] |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
